Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03040076 · ClinicalTrials.gov registry record · NA
Testing if Reductions in Negative Affect Yield Decreased Emotional Eating Symptoms
A NA study, sponsored by Florida State University.
- Terminated
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT03040076: Clinical Trial NA study, sponsored by Florida State University.
NCT03040076 is a NA study that was terminated before completion, run by Florida State University. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03040076, a NA study, was terminated before completion, sponsored by Florida State University.
- TERMINATED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this study to test a computerized treatment designed to help people with high levels of emotional eating, which is when people eat to cope with negative emotions and/or stressful situations. The investigators are interested in comparing two different ways of coping with negative emotions, relaxation training or training in how to think differently about such situations. Additionally, the researchers' study seeks to understand more about the psychological factors that may contribute to someone having difficulty with emotional eating.
Primary Outcome
Emotional eating will be measured using the 6-item Emotional Overeating Questionnaire (EOQ; Masheb \& Grilo, 2006), in which participants report on the frequency of eating in response to five negative emotions and one positive emotion. The instructions and item scaling will be modified to decrease the timeframe assessed from 28 days to 5 days, in order to be sensitive to changes during the present intervention. Each item will be assessed on a 5-point scale (0= no days to 5 = every day). Further,
Interventions
- BEHAVIORAL Cognitive Bias Treatment
- BEHAVIORAL Relaxation Condition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2017-03-28 |
| Est. Completion | 2017-05-03 |
| Phase | NA |
Why NCT03040076 stopped before completion
NCT03040076 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Cognitive Bias Treatment is the first listed.
NCT03040076 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03040076 about?
NCT03040076 is a clinical study titled "Testing if Reductions in Negative Affect Yield Decreased Emotional Eating Symptoms". The purpose of this study to test a computerized treatment designed to help people with high levels of emotional eating, which is when people eat to cope with negative emotions and/or stressful situations. The investigators are interested in comparing two different ways of coping with negative emoti...
What is the current status of trial NCT03040076?
This trial is currently terminated. It is a NA study. The enrollment target is 28 participants. The study started on 2017-03-28. Estimated completion is 2017-05-03.
What interventions are being tested in trial NCT03040076?
The interventions under investigation include: Cognitive Bias Treatment (BEHAVIORAL), Relaxation Condition (BEHAVIORAL).
Who is sponsoring clinical trial NCT03040076?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03040076's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI